EQS-Adhoc: MBB beats its 2024 guidance with revenues of €1.06 billion at an EBITDA margin of more than 13% based on preliminary figures and announces management changes

Disclosure of inside information acc. to Article 17 MAR

MBB beats its 2024 guidance with revenues of €1.06 billion at an EBITDA margin of more than 13% based on preliminary figures and announces management changes

Berlin, 16 January 2025 – MBB SE (ISIN DE000A0ETBQ4), a medium-sized family business, grew revenues by 11% to around €1,060 million in 2024, based on preliminary figures. At more than 13%, the adjusted EBITDA margin was not only almost 5 percentage points higher than in the previous year, but also exceeded the forecast of 12%, which had already been raised twice during the year. The main driver of this positive development was once again Friedrich Vorwerk, whose revenues of more than €495 million at an EBITDA margin of around 16% were well above expectations. Although MBB invested more than €58 million in the purchase of shares of MBB companies over the course of the year, the MBB Group's Net Cash reached a new record level of around €550 million at the end of the year, up around €75 million on the previous year.

Dr Constantin Mang (CEO) and Dr Jakob Ammer (COO) informed the Board of MBB SE at today's extraordinary Board meeting of their decision not to extend their management contracts, which expire on 30 June 2025. Dr Mang has been an integral part of the MBB team for more than 10 years. In almost seven years as a member of the Executive Management and in particular in the last four years as CEO of the Group, he has played a key role in the exceptional development of MBB. His successes include the IPO of Aumann as well as the acquisition and subsequent IPO of Friedrich Vorwerk. Dr Ammer has played a key role in shaping the operational development of MBB's subsidiaries since joining the company in 2020 and especially in the past four years as COO. In particular, he has provided strategic support for Friedrich Vorwerk's rapid growth and has made important contributions to the Group’s organizational development. The Board deeply regrets their decision and wishes to thank them for their outstanding achievements.

Dr Christof Nesemeier, founding shareholder and Executive Chairman, and Torben Teichler will jointly lead the company as its Executive Management from July 2025. Dr Nesemeier was today appointed by the Board as Executive Director for a further 4.5 years. As Executive Chairman, he will be responsible for Strategy, M&A and Operations. Mr Teichler was today appointed as CFO of MBB for a further term of 4.5 years and will be responsible for Capital Allocation, Finance and Investor Relations.

The Annual Report 2024 will be published on 31 March 2025 at www.mbb.com.
 

MBB SE
Joachimsthaler Straße 34
10719 Berlin
Tel +49 30 844 15 330
Fax +49 30 844 15 333
[email protected]
www.mbb.com 

Executive Management
Dr. Constantin Mang (CEO)
Dr. Jakob Ammer
Torben Teichler

Chairman of the Board and Executive Director
Dr. Christof Nesemeier

Court of Registration
Berlin-Charlottenburg Local Court, registration number: HRB 165458